HOME >> BIOLOGY >> NEWS
Francis Collins and Ari Patrinos receive Energy Secretary's Gold Award for Human Genome Project

WASHINGTON, DC -- Secretary of Energy Spencer Abraham today presented Francis Collins and Aristides Patrinos with the Secretary's Gold Award for their leadership of the government's Human Genome Project. Francis Collins is the director of the National Human Genome Research Institute at the National Institutes of Health, Department of Health and Human Services. Ari Patrinos heads the Office of Biological and Environmental Research at the Department of Energy's (DOE) Office of Science.

The award is the Energy Department's highest honorary award and includes a plaque with citation, a medallion and a rosette. Secretary Abraham presented Drs. Collins and Patrinos with the award in a ceremony at DOE headquarters. Director of the National Institutes of Health Elias Zerhouni represented the Department of Health and Human Services at the ceremony.

"These awards are in recognition of your vision and sustained leadership of the international human genome project, which culminated in the completion of the human DNA sequence in April 2003," Secretary Abraham said. "The project's success was largely due to your ability to join the efforts of two agencies: the Department of Health and Human Services' National Institutes of Health and the Department of Energy's Office of Science. This outstanding scientific and management accomplishment has opened the door to the biotechnology revolution that now offers such promise for human health, clean energy and a cleaner environment."

Francis Collins, a physician-geneticist, practiced medicine at North Carolina Memorial Hospital. Following a fellowship in human genetics at the Yale Medical School, he joined the faculty at the University of Michigan. His research there led to the identification of genes responsible for cystic fibrosis, neurofibromatosis, Huntington's disease and, this year, the gene that causes Hutchinson-Gilford progeria syndrome, a disorder that causes the most dramatic form of premature aging.
'"/>

Contact: Jeff Sherwood
jeff.sherwood@hq.doe.gov
202-586-4826
DOE/US Department of Energy
10-Sep-2003


Page: 1 2

Related biology news :

1. VIB presents its annual results at BIO2004 in San Francisco
2. Dr. Francis White, FUHS/CMS, receives MERIT Award
3. UC San Francisco patents method for delivering normal genes in a pill
4. Invasive cordgrass in San Francisco Bay
5. Life in ice scientist hopes for power in San Francisco
6. Taking the show on the road - Leading researchers to conduct hands-on science symposium for 500 San Francisco area high school students
7. Massive new research effort will map inner workings of cells - San Francisco VA Medical Center chosen to host core laboratory
8. A more accurate measure of exercise ability in older people reported by San Francisco VA Medical Center researchers
9. Futurist research highlights chemists national meeting March 26-30 in San Francisco
10. NASA Exhibit In San Francisco To Show How Space Research Improves Health Care On Earth
11. University Of California-San Francisco Researchers Report Test That Detects Prion Diseases, Illuminates Novel Findings About Infectious Prions

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... ... mitochondria, in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing in Ophthalmology ... VISTA-2 study of SkQ1 ophthalmic solution in patients with moderate to severe ...
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in Basel, ... license agreements with Housey Pharma’s HMI subsidiary to gain access to its core-enabling ... Research and Development spending in excess of US $10 billion. , Scientists at ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... (PRWEB) , ... August 11, ... ... a biopharmaceutical cold chain validation engineering firm, is making available for free ... the need to incorporate concurrent transport simulation testing into today’s biologics licensing ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering ... 50 million stem cells total, patients may choose which extremities they would like treated. ... joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the solution ... history of eSource, the reasons it did not take off as quickly as people ... the industry is moving towards capturing data electronically for clinical trials and then repurposing ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver ... “It’s the only technology of its kind on the market and we were pleased ... the protective capacity of traditional cultured ingredients, creating a natural way to extend the ...
Breaking Biology Technology:
Cached News: